Search

Author/Creator Siler, Thomas M.

1. A randomised, phase III trial of once-daily fluticasone furoate/vilanterol 100/25 μg versus once-daily vilanterol 25 μg to evaluate the contribution on lung function of fluticasone furoate in the combination in patients with COPD. (February 2017)

Authors:
Siler, Thomas M.; Nagai, Atsushi; Scott-Wilson, Catherine A.; Midwinter, Dawn A.; Crim, Courtney
Journal:
Respiratory medicine
Issue:
Volume 123(2017)
Page Start:
8
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Corrigendum to "Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies" [Respir. Med. 109 (2015) 1155–1163]. Issue 11 (November 2015)

Authors:
Siler, Thomas M.; Kerwin, Edward; Sousa, Ana R.; Donald, Alison; Ali, Rehan; Church, Alison
Journal:
Respiratory medicine
Issue:
Volume 109:Issue 11(2015)
Page Start:
1493
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis. (December 2022)

Authors:
Bardsley, Samuel; Criner, Gerard J.; Halpin, David M.G.; Han, MeiLan K.; Hanania, Nicola A.; Hill, David; Lange, Peter; Lipson, David A.; Martinez, Fernando J.; Midwinter, Dawn; Siler, Thomas M.; Singh, Dave; Wise, Robert A.; van Zyl-Smit, Richard N.; Berkman, Neville
Journal:
Respiratory medicine
Issue:
Volume 205(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗